Rohini Kalvakuntla

Co-Founder & Chief Business Officer Helex

Seminars

Monday 16th March 2026
Panel Discussion: Novel Delivery Modalities & Gene Therapy Approaches in PKD
1:50 pm
  • Exploring gene therapy, antisense oligonucleotides, and CRISPR-based approaches
  • Overcoming delivery barriers to the kidney
  • Designing preclinical studies with translational relevance
  • Regulatory considerations for first-in-human studies
Rohini